Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference45 articles.
1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
2. Pantelidou C, Sonzogni O, De Oliveria TM, Mehta AK, Kothari A, Wang D et al (2019) PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer. Cancer Discov 9(6):722–737
3. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203–213
4. Zhang G, Liu C, Bai H, Cao G, Cui R, Zhang Z (2019) Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment. Oncol Lett 17(3):2583–2591
5. Ghisoni E, Imbimbo M, Zimmermann S, Valabrega G (2019) Ovarian cancer immunotherapy: turning up the heat. Int J Mol Sci. 20(12):2927
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献